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Summary
Objective:  Community-acquired  pneumonia  (CAP)  is  a  major  cause  of  morbidity  and
mortality  worldwide.  Herein,  we  present  the  ﬁndings  from  an  audit  of  CAP  manage-
ment  at  a  tertiary  hospital  in  Oman.  The  main  objective  was  to  evaluate  the  quality
of  care  given  to  patients  and  compare  it  with  the  standards  in  the  Gulf  Cooperation
Council  (GCC)  CAP  guidelines.
Methods:  A  retrospective  case  study  of  all  patients  admitted  with  CAP  from  June
2006  to  September  2008  examined  the  adherence  to  standards  for  the  diagno-
sis,  investigation,  and  management  of  CAP,  including  the  documentation  of  illness
severity.
Results:  The  case  notes  of  342  patients  were  reviewed.  Of  these,  170  patients  were
excluded  from  the  study,  and  172  patients  met  the  diagnostic  criteria  for  inclu-
sion.  A  CURB-65  severity  score  was  documented  for  only  4  (2.3%)  patients,  and
a  smoking  history  was  documented  for  56  (32.6%)  patients.  Although  17  different
antibiotic  regimens  were  used,  115  (67%)  patients  received  co-amoxiclav  and  clar-
ithromycin,  which  is  the  standard  of  care.  Additionally,  139  (81%)  patients  received
their  ﬁrst  dose  of  antibiotics  within  four  hours  of  hospital  admission.  There  was  no
documentation  of  offering  inﬂuenza  or  pneumococcal  vaccine  to  high  risk  patients.
Conclusion:  The  clinical  coding  of  CAP  diagnosis  was  poor.  There  was  very  poor
adherence  to  the  CAP  severity  assessment  and  the  provision  of  preventive  measures
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.  The  development  and  implementation  of  a  local  hospital-
athway  may  lead  to  more  successful  implementation  of  the
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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ommendations  for  immunization  against  inﬂuenza
or pneumococcal  diseases.
In the  GCC  guidelines,  illness  severity  isupon  hospital  discharge
based  integrated  care  p
guidelines.
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ommunity-acquired  pneumonia  (CAP)  is  a  major
ause of  morbidity  and  mortality  worldwide  and
s managed  by  different  disciplines  in  a het-
rogeneous fashion.  Wide  variation  exists  in  the
anagement  of  patients  hospitalized  with  CAP,
espite  the  development  of  numerous  national
nd specialist  society  clinical  guidelines  over  the
ast 15  years  [1].  The  appropriate  management  of
AP includes  the  accurate  classiﬁcation  of  disease
everity  to  indicate  the  optimal  intervention  [2].
he implementation  of  management  guidelines  and
heir maintained  adherence  should  reduce  morbid-
ty, mortality  and  health  care  costs  [3,4].  There  is
vidence that  guidelines  can  direct  and  standard-
ze disease  management,  but  the  effects  on  disease
utcome  are  less  measurable  [5].
The  adherence  to  guidelines  for  CAP  manage-
ent or  to  other  antibiotic  policies  by  hospital
hysicians has  been  rarely  evaluated  in  the  Mid-
le East,  and  no  data  are  available  from  Oman
r other  Gulf  Cooperation  Council  (GCC)  coun-
ries. The  guidelines  for  CAP  management  have
een developed  for  the  GCC  area  by  a  large
egional/international  multidisciplinary  Working
roup (GCC  CAPWG),  which  collaborated  in  a full
eview  of  the  current  international  and  local  data  to
nform the  publication  and  promotion  of  evidence-
ased graded  recommendations  suitable  for  the
egion [6—10].
We  conducted  an  audit  of  the  quality  of  care
or CAP  in  the  acute  medical  admission  unit  of  a
ertiary  hospital  in  Oman  and  compared  the  data
o the  GCC  CAP  guideline  standards.  The  study
ocused primarily  on  the  illness  severity  scoring  at
he time  of  admission,  the  proportion  of  patients
eceiving  appropriate  antibiotics  within  four  hours
f admission  to  the  hospital,  and  the  preventive
easures instituted  for  patients  at  the  time  of
ospital  discharge.
ethodshe  Royal  Hospital  (RH)  is  a  650  bed  tertiary
are hospital  serving  the  Muscat  area  and  a  refer-
al hospital  for  patients  from  all  over  Oman.  A
a
a
letrospective  case  study  included  all  patients  with
 discharge  diagnosis  of  pneumonia  from  June  2006
o September  2008.  During  this  period,  the  GCC
AP guidelines  were  presented  several  times  at  the
epartment  of  Medicine  biweekly  meetings,  which
re attended  by  all  interns,  residents  in  training  and
onsultants.
Patients were  identiﬁed  from  the  computerized
ctivity registers  of  the  hospital,  and  all  patients
ith a discharge  code  of  pneumonia  (ICD  10  codes
15.9, J16  and  J18)  were  included.  The  hospital
ase notes  were  fully  computerized  and  reviewed
or all  patients.  Those  found  not  to  have  CAP  were
xcluded  from  further  analysis.  The  diagnosis  of
AP was  based  on  the  deﬁnition  of  pneumonias
iven in  the  GCC  guidelines,  which  relies  on  the
resence  of  select  clinical  features  (e.g.,  cough,
ever, sputum  production,  and  pleuritic  chest  pain)
nd is  supported  by  imaging  of  the  lung,  usually  by
hest radiography  [6].  Pneumonia  was  deﬁned  as
eing community  acquired  if  present  at the  time  of
dmission to  the  hospital  or within  48  h of  admis-
ion, without  evidence  of  admission  to  an  acute
are hospital  for  two  or  more  days  within  90  days
rior to  the  infection.
Patients  with  aspiration  pneumonia,  exacer-
ations of  chronic  pulmonary  diseases  or  with
ospital-acquired  pneumonia  were  excluded,  as
ere immunosuppressed  patients  and  patients
ith sickle-cell  disease.  Patients  who  were  later
iagnosed  with  pulmonary  tuberculosis  were  also
xcluded.
A standard  form  was  used  to  record  the  relevant
ata for  eligible  patients.  The  collected  data  items
ncluded  the  following:  basic  demographic  infor-
ation;  the  components  of  severity  scoring;  the
lood, sputum  and  radiological  investigations  per-
ormed and  their  timing;  the  antibiotics  prescribed
nd their  route  of  administration  and  timing;
nd follow  up  after  discharge  and  the  preventive
easures advised  prior  to  discharge,  i.e.,  the  rec-ssessed using  the  CURB-65  score  [7]  as  ‘‘core’’
nd ‘‘additional’’  adverse  prognostic  factors,  the
atter based  on  the  presence  of  hypoxemia  and/or
252  S.S.  Al-Abri  et  al.
Table  1  Key  items  included  on  audit  forms.  The  performance  indicators  for  community-acquired  pneumonia  were
taken  from  the  GCC  guidelines  [6—10]. The  denominator  is  172  patients  unless  otherwise  speciﬁed.
Key  audit  domains  Performance  indicators  Outcome  N  (%)
Investigations
CURB-65  Performed  upon  admission  4  (2.3)
Chest  X-ray  Performed  upon  admission  172  (100)
Complete  blood  count  Performed  upon  admission  172  (100)
CRP/ESR Performed  upon  admission 143  (83)
Renal  function  test Performed  upon  admission 172  (100)
Liver  function  test Performed  upon  admission 139  (81)
Blood  culture For  patients  with  severe  CAP 158  (92)
Sputum  microscopy  If  a  drug-resistant  or  unusual  pathogen  is
suspected
83  (48)
Sputum  examination  for  acid-fast  bacilli If  symptoms  are  suggestive  of  TB  76  (44)
Serology  for  atypical  microorganisms  For  patients  with  severe  CAP  0  (0)
Oxygen  saturation  Performed  upon  admission  140  (76)
Arterial  blood  gas  analysis  Performed  if  oxygen  saturation  was  less
than  92%
33/77  (43)
Antimicrobial  therapy
Time  to  ﬁrst  antibiotic  dose  To  be  given  within  4  h  of  arrival  at
hospital
139  (81)
Location  of  administration  of  initial  dose  of
antibiotics
First  dose  to  be  administered  in  the
emergency  room
0 (0)
Time  to  switch  from  IV  to  oral  therapy Switch  from  intravenous  to  oral  therapy
by  the  third  day  of  therapy
105  (61)
Total  duration  of  antibiotic  therapy Minimum  of  5  days  of  antibiotic  therapy 167  (97)
Antibiotic  regimen Cover  for  atypical  micro-organisms 157  (91)
Preventive  measures
Pneumococcal  vaccination  To  be  offered  to  speciﬁc  high-risk  groups  0  (0)
Seasonal  inﬂuenza  vaccination  To  be  offered  to  patients  at  high  risk  for
inﬂuenza-related  complications  and
severe  diseases
0  (0)
Smoking  history  To  be  obtained  from  all  patients  56  (33)
Cigarette  smoking  cessation  counseling  To  be  offered  to  all  current
acco
0/25  (0)
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bilateral  or  multilobar  involvement  on  chest  X-rays.
A CURB-65  score  of  0  or  1  for  each  of  the  5  points
produces a  prognostic  index  outcome  score  of  0,
suggesting  a  30  day  mortality  risk  of  0.7%,  while
a score  of  5 predicts  a  57%  mortality  risk.  Severe
CAP is  deﬁned  by  a  score  of  ≥3  [11].
The  GCC  standards  for  ﬁrst-line  antimicro-
bial therapy  for  CAP  include  respiratory  ﬂuo-
roquinolones or  a  combination  of  a  -lactam
with an  advanced-generation  macrolide  for  inpa-
tients who  are  not  admitted  to  the  intensive
care unit  (ICU)  and  a  -lactam  with  either  an
advanced-generation  macrolide  or  respiratory  ﬂu-
oroquinolones  for  patients  who  are  admitted  to  the
ICU but  do  not  have  the  risk  factors  associated
with Pseudomonas  aeruginosa  or  MRSA  infection.
Antibiotics should  be  received  within  four  hours
of hospital  admission,  and  adults  should  receive  a
minimum of  ﬁve  days  of  antibiotics.  Early  respon-
ders who  can  tolerate  oral  therapy  should  have
n
d
d smokers
heir  therapeutic  regimen  changed  (typically  by the
hird day  of  therapy)  if  they  show  clinical  stability.
tandards for  immunization  include  annual  admin-
stration  of  the  inﬂuenza  vaccine  to  individuals  at
igh risk  for  inﬂuenza-related  complications  and
evere disease,  including  people  of  any  age  with
peciﬁc  chronic  medical  conditions,  persons  aged
50 years  of  age,  and  pregnant  women.  The  pneu-
ococcal  polysaccharide  vaccine  is  recommended
or speciﬁc  high-risk  groups,  including  individuals
ith chronic  cardiovascular,  pulmonary,  renal  or
iver disease,  cerebrospinal  ﬂuid  leaks,  diabetes
ellitus, asplenia,  or  immunocompromised  condi-
ions and  long-term  care  facility  residents.
The data  were  entered  into  Microsoft  Excel  2007
ith password  protection  and  were  anonymized
fter checking  for  errors  against  the  original  case
otes by  sorting  and  manual  inspection.  Simple
escriptive  statistics  were  used  to  summarize  the
ata.
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Table  2  First  antibiotic  choice  in  172  patients  hospitalized  with  community-acquired  pneumonia  in  Oman,  in  order
of  frequency.  All  medications  were  given  intravenously.
Combination  regimen  Number  (%)  Single  agent  Number  (%)
Co-amoxiclav  +  clarithromycin  119  (69)  Co-amoxiclav  9  (5)
Cefuroxime  +  clarithromycin  10  (6)  Piperacillin-tazobactam  5  (3)
Ceftriaxone  +  clarithromycin 8  (5)  Cefuroxime  3  (1.7)
Piperacillin-tazobactam  +  clarithromycin 6 (3.5)  Meropenem  2  (1)
Co-amoxiclav  +  clarithromycin  +  aciclovir 2 (1)  Ceftriaxone 1 (0.6)
Co-amoxiclav  +  clarithromycin  +  ﬂucloxacillin 1 (0.6)  Ciproﬂoxacin 1 (0.6)
Co-amoxiclav  +  clarithromycin  +  metronidazole 1 (0.6)
Ceftriaxone  +  ciproﬂoxacin  1  (0.6)
Cefuroxime  +  erythromycin  1  (0.6)
Co-amoxiclav  +  metronidazole  1  (0.6)
1  (0.
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esults
uring  the  27  month  study  period  from  June  2006
o September  2008,  342  patients  were  identiﬁed  as
aving pneumonia  at  the  time  of  hospital  discharge.
n all,  170  (49.7%)  patients  who  were  discharged
ith a  diagnosis  of  CAP  were  miscoded,  leaving  172
atients enrolled  in  the  study.
The majority  of  patients  were  male  (106;  62%),
nd 123  (71.5%)  patients  were  less  than  65  years
f age.  Most  admissions  occurred  during  the  winter
62, 36%)  and  spring  (52,  29.3%),  with  only  31  (18%)
n the  summer  and  27  (16.7%)  in  the  autumn.  Addi-
ionally,  53  (31%)  patients  had  co-morbidities,  and
5 (44.6%)  of  56  patients  from  whom  a  smoking  his-
ory was  obtained  were  current  tobacco  smokers.
he median  length  of  stay  in  the  hospital  (LOS)  was
ight days;  in-hospital  mortality  was  observed  in  six
3.4%) patients.  Table  1  summarizes  the  main  audit
esults.
A severity  assessment  using  the  CURB-65  score
as only  recorded  for  4  (2.3%)  patients,  and  140
76%) patients  had  measurements  of  oxygen  satura-
ion at  the  time  of  admission.  An  arterial  blood  gas
nalysis was  performed  for  33  (43%)  of  the  patients
hose  initial  oxygen  saturation  was  less  than  92%.
omplete  blood  counts,  urea  and  electrolyte  mea-
urements  and  chest  X-rays  were  performed  for  all
f the  patients  at  the  time  of  admission.  Blood
ultures were  taken  from  158  (92%)  patients,  and
-reactive  protein  (CRP)  was  measured  in  143
83%) patients.  All  sputum  samples  were  evalu-
ted  using  Gram  staining;  sputum  samples  from  83
48%) patients  were  cultured,  and  those  from  76
44%) patients  were  cultured  for  TB  and  evaluated
sing acid-fast  staining.  Liver  function  tests  were
equested  for  139  (81%)  patients.
17 different  antibiotic  regimens  were  used
Table 2),  including  the  following:  115  (67%)
i
m
I
n6)
atients  received  a  combination  of  co-amoxiclav
nd clarithromycin;  9 (5%)  patients  received
efuroxime and  clarithromycin;  15  (9%)  patients
id not  receive  antimicrobial  cover  for  atypical
athogens. Although  139  (81%)  patients  received
ntibiotics within  four  hours  of  arrival  at  the  hospi-
al, no  patient  received  the  ﬁrst  dose  of  antibiotics
n the  emergency  room.  All  patients  received  par-
nteral antibiotics,  and  105  (61%)  were  switched
rom intravenous  to  oral  agents  before  discharge
rom the  hospital.  The  switch  from  intravenous  to
ral antibiotics  was  made  on  the  fourth  or  ﬁfth  day
ollowing  admission  for  79  (46%)  patients.
A follow-up  chest  X-ray  was  performed  for  42
24%) patients,  usually  4—7  weeks  following  dis-
harge,  which  is  the  standard  of  care.  However,  a
hest X-ray  was  performed  only  two  to  three  weeks
ollowing  discharge  for  nine  (22%)  of  these  patients.
here  was  no  documentation  of  either  the  pneumo-
occal  or  inﬂuenza  vaccine  being  offered  to  any  of
he high-risk  patients  or  of  counseling  on  the  ces-
ation of  cigarette  smoking.
iscussion
ommunity-acquired  pneumonia  is  a  common
iagnosis and  results  in  signiﬁcant  healthcare
xpenditure, mostly  for  patients  who  require  hos-
italization  [12].  It  is  also  one  of  the  most  common
nfections  for  which  antibiotics  are  prescribed.
owever, it  is  poorly  coded  in  hospital  discharge
tatistics, as  shown  in  this  audit  where  only  50.3%  of
atients coded  as  having  CAP  were  conﬁrmed  by a
etailed examination  of  the  case  notes.  Similar  cod-
ng problems  have  been  noted  in  British  studies  [2],
aking audits  such  as  this  more  difﬁcult  to  perform.
naccuracy  of  coding  raises  doubts  about  the  useful-
ess of  large-scale  inter-institutional  comparisons
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of  patient  outcome  data  that  rely  on  routine  coding
alone without  re-examination  of  the  clinical  care
details.
Nevertheless,  studies  have  shown  signiﬁcant
variation between  institutions  with  respect  to
antibacterial  usage  and  length  of  stay  (LOS)  for
CAP, although  these  variations  do  not  appear  to  be
associated  with  signiﬁcant  differences  in  patient
outcomes.  This  information  has  stimulated  the
development  of  practice  guidelines  and  clinical
pathways to  optimize  the  care  of  patients  with
CAP. This  audit  has  shown  that  most  (81%)  patients
received  the  appropriate  antibiotics  for  CAP  within
four hours  of  hospital  admission,  a  ﬁgure  that  com-
pares favorably  to  the  58%  of  patients  described
in a  recent  national  British  Thoracic  Society  audit
[13]. However,  compliance  with  many  elements  of
the international  and  regional  guidelines  was  poor,
including critical  components  such  as  the  assess-
ment  of  illness  severity  at  the  time  of  admission
and the  implementation  of  appropriate  preventive
measures for  patients  at  the  time  of  discharge.  This
study is  the  ﬁrst  such  audit  in  the  GCC  region  and
sets a  benchmark  for  local  improvement  and  for
comparison  with  other  institutions  in  the  region.
Although the  GCC  CAP  guidelines  and  other
CAP management  guidelines,  such  as  those  of  the
British Thoracic  Society  (BTS)  [14]  and  the  Infec-
tious Diseases  Society  of  America  [15],  have  been
presented  several  times  to  doctors  at  the  Depart-
ment of  Medicine  meetings,  this  audit  shows  very
poor recording  of  CAP  severity  using  the  CURB-65
score when  patients  were  ﬁrst  assessed  and  diag-
nosed in  our  hospital.  Assessing  the  CURB-65  score
helps stratify  patients  and  guides  the  decisions  of
the treating  doctor  with  respect  to  the  patient
site of  care.  Non-adherence  to  the  use  of  severity
scores has  been  reported  in  other  studies  [2,5,16].
One study  has  shown  that  between  50%  and  78%  of
patients with  CAP  may  be  admitted  unnecessarily
when the  CURB-65  score  is  not  being  used  [17].
However,  it  is  possible  that  the  physicians  made
severity  assessments  that  guided  their  antibiotic
choice but  simply  did  not  document  them.
Most patients  (115,  67%)  with  CAP  received
co-amoxiclav  and  clarithromycin  as  recommended
in the  GCC  CAP  guidelines.  However,  there  was
excessive  prescription  of  intravenous  macrolides,
which other  studies  have  shown  to  be  poor  prac-
tice [2,12,18]. Barlow  et  al.  reported  a  trend  for
increasing  broad-spectrum  antibiotic  use,  which
accelerated  after  the  introduction  of  the  BTS
guidelines  [19].  This  trend  was  attributed  to
a ‘‘just-in-case’’  approach  being  adopted  with
regards  to  antibiotic  choice  for  less  severely  ill
patients.
t
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Most  studies  evaluating  the  effects  of  adher-
nce to  CAP  guidelines  have  shown  positive  results,
ncluding  shortened  durations  of  antibiotic  treat-
ent,  better  coverage  of  atypical  pathogens,  and
mproved appropriateness  of  antibiotic  therapy.  In
ddition, following  CAP  guidelines  is  associated
ith improved  door-to-antibiotic  time,  administra-
ion  of  antibiotics  within  four  hours  of  hospital
rrival, and  a shorter  time  before  switching  ther-
peutic  regimens  [20—22].  Guideline  adherence  is
lso associated  with  a  shorter  duration  of  mechani-
al ventilation  and  ICU  stay  in  patients  with  severe
AP [20]  and  overall  shorter  length  of  hospital  stay,
 shorter  time  to  stability  and  decreased  in-hospital
nd 30-day  mortality  rates  [4,22—25].  There  is good
vidence that  following  the  recommendations  of
he CAP  guidelines  improves  the  cost-effectiveness
f care  [21,26].
However,  a systematic  review  of  studies  eval-
ating guideline  implementation  strategies  found
nly modest-to-moderate  effects  and  noted  that
ealthcare  organizations’  resources  for  guideline
mplementation  were  usually  insufﬁcient  to  allow
uch more  than  the  dissemination  of  educational
aterials or  lunchtime  educational  meetings,  inter-
entions whose  effects  were  usually  only  short  lived
27]. Education-  and  audit-based  interventions  used
efore the  implementation  of  guidelines  showed
 signiﬁcant  increase  in  the  prescription  of  the
ppropriate  antibiotics  after  the  introduction  of  a
‘multifaceted  education  program’’  [1,21].  Audit-
eedback systems  to  improve  the  quality  of  care
ave also  been  shown  to  be  feasible  and  effective
n hospital  settings  in  low-income  countries  [28].
Qualitative  studies  showed  that  undergraduate
ducation about  antimicrobials  needs  to  be  more
ractical  and  easier  to  apply  to  on-ward  situations;
ospital guidelines  need  to  be  effectively  dissemi-
ated and  presented  in  a user-friendly  format  [29].
arlow et  al.  showed  that  doctors  thought  they
new the  criteria  for  the  assessment  of  CAP  sever-
ty; although  the  more  senior  physicians  were  able
o state  the  criteria  correctly,  they  were  very  poor
t putting  this  information  into  practice  [1].  There-
ore, education  about  guideline  content  is  unlikely
o change  behavior  unless  it  is  accompanied  by
egular  feedback  about  doctors’  adherence  to  key
uideline  recommendations  [30].  It  is  advisable  to
ake the  CURB-65  criteria  and  antibiotic  policies
eadily  accessible  online  and  through  posters  in  the
ards. In  addition,  undergraduates  and  postgrad-
ates  should  be  advised  not  to  try  to  remember
he CURB-65  criteria,  as  they  will  inevitably  confuse
hem with  other  clinical  scores  [31].
Quality-assessment  indicators  for  community-
cquired pneumonia  (CAP),  which  were  founded  on
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[n  audit  of  inpatient  management  
he  health  care  structure,  process,  and  outcome,
ave been  recommended  as  potential  audit  tools  to
valuate the  delivery  of  care.  This  recommendation
as resulted  in  the  development  and  implemen-
ation of  care  bundles  and  local  hospital-based
ntegrated care  pathways  [32].  Successful  guide-
ine implementation  programs  need  to  understand
ocal barriers,  incorporate  multiple-component
nterventions,  and  proceed  within  a  framework
f continuous  quality  improvement  [1,33].  Local
ntibiotic  committees  should  take  such  factors  into
ccount when  implementing  national  guidelines  at
 local  level  [34].
This  audit  highlights  the  key  clinical  components
f the  GCC  guidelines,  including  some  that  would
ow be  more  controversial,  such  as  the  insistence
n routine  Gram  stains  of  sputum  in  all  patients
ith CAP  [14]  and  the  safety  and  desirability  of
erforming  routine  follow-up  chest  X-rays  for  all
oung adults  (<50  years  of  age)  with  uncompli-
ated CAP.  This  audit  should  help  local  committees
ocus on  speciﬁc  elements  of  the  guidelines  that
re important  to  emphasize  in  local  implementa-
ion pathways.  Future  studies  on  CAP  management
hould use  rigorous  study  designs  and  multiple
vidence-based  strategies  to  change  current  prac-
ices. They  should  also  convincingly  demonstrate  to
ront-line health  care  providers  that  the  suggested
nterventions are  safe  and  will  improve  patient  out-
omes [33].
In  summary,  this  is  the  ﬁrst  audit  of  the
mplementation  of  detailed  regional  guidelines  for
he investigation  and  management  of  a  common
nfectious problem  in  the  GCC  area.  The  clinical
utcomes of  hospital  care  for  CAP  were  compara-
le with  other  local  studies  [6—10,35],  and  some
lements  of  care  were  well  documented.  However,
ther elements  of  the  guidelines  were  poorly  fol-
owed or  documented,  including  the  following:  the
ssessment  of  illness  severity  upon  hospital  admis-
ion, which  should  guide  many  subsequent  elements
f care;  the  timing  of  post-discharge  radiological
ollow up;  and  preventive  measures  for  high-risk
atients at  the  time  of  hospital  discharge.  The
tudy  provides  a  benchmark  for  local  and  regional
omparisons and  emphasizes  the  need  for  inclu-
ion of  a  standardized  audit  tool  in  future  regional
uidelines,  as  recommended  by  other  guideline
evelopment groups  [13].onﬂict of interest
he  authors  declare  that  there  are  no  conﬂicts  of
nterest.
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